HemaSphere (Jun 2022)

P392: PHARMACOLOGICAL INHIBITION OF SYK CONFERS ANTI-PROLIFERATIVE AND NOVEL ANTI-TUMOR IMMUNE RESPONSES IN AML

  • L. A. Carvajal,
  • B. Robinson,
  • Y. Kosaka,
  • T. Jacob,
  • J. Lee,
  • T. Hood,
  • K. Baker,
  • A. Kaempf,
  • S. N.-A. Amara,
  • J. Pucilowska,
  • E. Lind,
  • C. Tognon,
  • J. Tyner,
  • P. Kumar,
  • T. Vu,
  • J. DiMartino

DOI
https://doi.org/10.1097/01.HS9.0000844456.64162.e9
Journal volume & issue
Vol. 6
pp. 292 – 293

Abstract

Read online

No abstracts available.